Insights from 2023 ESGO Annual Meeting
ESGO 2023 Insights: "Long-Term Follow Up of Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Endometrial Cancer"
By
Insights from 2023 ESGO Annual Meeting
FEATURING
Jose Perez-Fidalgo
By
Insights from 2023 ESGO Annual Meeting
FEATURING
Jose Perez-Fidalgo
Login to view comments.
Click here to Login